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Escherichia coli is one of the most widely used hosts for the production of recombinant proteins but insoluble expression of
heterologous proteins is a major bottleneck in production of recombinant proteins in E. coli. In vitro refolding of inclusion body
into proteins with native conformations is a solution for this problem but there is a need for optimization of condition for each
protein speciﬁcally. Several approaches have been described for in vitro refolding; most of them involve the use of additives for
assisting correct folding. Cosolutes play a major role in refolding process and can be classiﬁed according to their function as
aggregation suppressors and folding enhancers. This paper presents a review of additives that are used in refolding process of
insoluble recombinant proteins in small scale and industrial processes.
1.Introduction
The expression of recombinant products is an essential
method for producing target proteins and one of the most
important unit processes for production of therapeutic
protein and structural study [1–6]. There are diﬀerent
expression systems for producing recombinant protein in
biotechnology industry. Expression in mammalian cells
produces active recombinant proteins that have posttrans-
lation modiﬁcation but expression by this system is time
consuming and expensive. Although bacteria still represent
a convenient production system, most of recombinant
polypeptides produced in prokaryotic hosts undergo mis-
folding or incomplete folding processes that usually result
in their accumulation as insoluble aggregates, which called
inclusion bodies [7–9]. All these studies of recombinant
protein expression in Escherichia coli showed that inclusion
body formation is the rule rather than the exception.
In vitro refolding is required for obtaining active protein
from inclusion body aggregates which consist of four main
steps: inclusion body isolation, solubilization, refolding, and
puriﬁcation. Because of high density of IBs, they separated
easily by centrifuge. After isolation of the IBs, the proteins
contained in the inclusion bodies need to be solubilized,
usually by high concentration of denaturing agents such as
urea or guanidinium chloride (Gn-HCl). Then, solubilized
IBs are subjected for refolding in speciﬁed conditions.
Refolding of proteins from inclusion bodies is inﬂuenced by
diﬀerent factors including solubilization method, removal
of the denaturant, and assistance of refolding by co-solute
or additives. The refolding condition is critical in order
to obtain acceptable amounts of active protein. It has
been known that additives, especially low molecular weight
compounds, may signiﬁcantly enhance the yield of the
refolding process. In many cases, inclusion body protein can
only be successfully refolded by making use of these eﬀects.
2.Cosolute Assistance
Low molecular weight additives are usually added to refold-
ing buﬀer to promote the refolding process. In the case of
refolding by dilution, there is a residual concentration of
Guanidine HCl or urea in refolding buﬀer. This low con-
centration of denaturants holds aggregate prone structures
of target protein in soluble and ﬂexible state; thus refolding
yield eﬃciency improves. Due to this reason, additional to
residual concentration of denaturants, additives should be
added to refolding buﬀer to decrease the degree of aggregates
and misfolds. Co-solute may be classiﬁed into two groups:2 Biochemistry Research International
Table 1: Examples of buﬀer additives which may be used to





Guanidine HCl 0.1–1M Chaotroph
L-arginine 0.4–0.5M Stabilizer
Laroylsarcosin Up to 4M Detergent
MgCl2/CaCl2 2–10mM Cation
NaCl/Ammonium sulfate 0.2–0.5M Salt
Non-detergent sulfo betain Up to 1M Solublizer
PEG 3350 Up to 0.5%W/V Osmolyte
SDS 0.1% Detergent
Sodium citrate/sulfate 0.2–0.5M Salt
Sucrose/glucose Up to 0.75M Stabilizer
TMAO 1–3M Osmolyte
Tris 0.4–1M Buﬀer
Triton X-100 0.1–1% Detergent
Tween-80 0.01% Detergent
Glycine Up to 1M Osmolyte
Proline Up to 1M Osmolyte
Urea 0.1–2M Chaotroph
folding enhancer and aggregation suppressor. In principle,
foldingenhancerenhancesprotein-proteininteraction,while
aggregation suppressor reduces side chain interactions [4,
17].
The folding enhancers facilitate interaction between
proteins and thus increase the stability of proteins whereas
aggregation suppressor reduces side chain interaction of
foldingintermediateswithoutinterferingwithrefoldingpro-
cess[4].Commonadditivesusedinrefoldingofrecombinant
proteins are shown in Table 1.
3.Arginine(Arg)
Arginine is one of the useful reagents that are eﬀective in
assisting refolding of recombinant proteins from inclusion
bodies. It is an aggregation suppressor that improves refold-
ing yield; however, the mechanism of arginine action during
refolding is still unclear. ARGININE was ﬁrst used in re-
folding of human tissue type plasminogen activator [18,
19]. Since then, it has been used for refolding of a variety
of proteins including casein kinase II, [20], Fab antibody
fragments [18, 21], growth hormone [22], human gamma
interferon, [23], human matrix metalloproteinase-7 human
neurotrophins [24] human p53 tumor suppressor protein
[25], interleukin-21 [26], interleukin-6 receptor [27], ly-
sozyme [28], single-chain Fv fragments [29], and single-
chain immunotoxins [18, 30]. However, arginine may act
as a protein-denaturant, which limits the expansion of its
applications. Yancey et al. [31] showed that the activity
and stability of certain enzymes were perturbed by arginine
and concluded that arginine is a protein-destabilizer. Xia
et al. [32] have made a similar observation and showed
that ﬂuorescence properties of aminoacylase are perturbed
by arginine. They interpreted the observed eﬀects of arginine
in terms of denaturing property of the guanidinium group,
which makes guanidine hydrochloride (Gn-HCl) a strong
denaturant. But arginine diﬀers from Gn-HCl in the mode
of interactions with proteins.
4. Cyclodextrins (CDs)
Cyclodextrins have been reported to suppress aggregate for-
mation during the refolding of recombinant proteins. These
cyclic glucose macromolecules have hydrophobic cavities
and functional groups that can interact with polypeptide
chains by weak forces similar to those involved in protein
folding. CDs may interact with proteins via hydrophobic
forces, hydrogen bonding, and Van der Waals interactions.
Charged chemically modiﬁed CDs can also bind to the
folding polypeptide chain via electrostatic interactions. CDs
have been investigated in both dilution additive and artiﬁcial
chaperone-assisted modes. CDs have been used as stripping
agents for removal of detergents in proteins refolded with
surfactants [33, 34]. CDs have been used for refolding of
recombinant-human growth hormone [35]a n dα amylase
[36].
5.Polyethylene Glycol (PEG)
Polyethylene glycol is one of the water-soluble polymers that
are used for refolding of recombinant proteins [37]. PEG, a
polyhydric alcohol, like other polyols is known to stabilize
protein conformations as well as to increase the rate of in
vitro protein refolding [38, 39].
It enhances the recovery of active protein by prevent-
ing aggregation during refolding [40]. PEG improves in
vitro structure formation, which can block aggregation by
combining with a molten globule folding intermediate.
It stabilizes proteins by chemical modiﬁcation [41, 42].
PEG binds an intermediate in the folding pathway of
carbonic anhydrase, therefore prevents self-association and
promotes correct refolding [43–45]. PEG interacts with
the hydrophobic side chains exposed upon unfolding at
high temperatures [46]. PEG has been successfully used for
refolding of interferon [47], xylanase [48], and insulin-like
growth factor (IGF-1) [49] from inclusion bodies.
6. Proline (Pro)
The role of proline was studied for the ﬁrst time in in vitro
refolding of bovine carbonic anhydrase. Proline inhibited
bovine carbonic anhydrase aggregation and enabled the
protein to return to its native structure. It was proposed
that proline acts as a protein-folding chaperone due to
the formation of an ordered, amphipathic supramolecular
assembly [50]. Later, proline was found to prevent aggrega-
tion during hen egg-white lysozyme refolding. Also proline
has been used during refolding of arginine kinase [32]a n d
aminoacylase [51]. Proline inhibits protein aggregation byBiochemistry Research International 3
Table 2: Lists of smart polymers which are used in refolding procequres.
Smart polymer Sensitive Protein Reference
Eudragit S100 pH hbFGF/haFGF [10]
Alginate Ca++ Lipase Amilas [11, 12]
Poly(propylene oxide)−phenyl−poly(ethylene glycol)/PPO
(n) 33, PPO (n)5 0
Temperature Carbonic anhydrase [13, 14]
Poly(N-isopropylacrylamide) Temperature Carbonic anhydrase lysozyme [15, 16]
binding to folding intermediates. Proline (1M) was also
found to act as a creatin kinase (CK) folding aid [52]. Results
further indicate that proline possibly binds to and stabilizes
folding intermediates and reduces the hydrophobic surface
of CK, thus inhibiting protein aggregation and improving
the ﬁnal yield of CK. The unusual properties of proline
may be due to hydrophobic stacking in aqueous solution
and intermolecular self-association [53]. The hydrophobic
nature of proline covers hydrophobic region of the proteins,
through which this amino acid eﬀectively suppresses protein
aggregation [54].
7. Ammonium Sulfate((NH4)2SO4)
Salts can stabilize proteins through nonspeciﬁc electrostatic
interactions at low concentration, dependent on the ionic
strength of the medium [55]. At high concentrations, salts
exert speciﬁc eﬀects on proteins depending on the type and
concentration of the salts, resulting in either the stabilization
or destabilization of proteins, or even denaturation [56].
Salts usually increase interfacial tension between the protein
surface and solvent [57], which leads to increase the sol-
ubility of proteins and aggregates, although the stabilizing
eﬀect of salts on protein structure is closely correlated to the
salting-out eﬀect of salts.
Ammonium sulfate is widely used as a precipitant for
protein puriﬁcation and for crystallization, as this salt can
prevent aggregation. Ammonium salts have been reported
to prevent heat-induced aggregation of lysozyme [58]. Also
magnesiumchlorideisanotherexampleofsaltsthathasbeen
used in refolding of recombinant proteins [59].
8. Polyols
Polyols vary in length of carbon chain and number of
hydroxyl groups. Polyols used as additives for enhancing
refolding yield and stabilize protein structure. The structure-
stabilizing polyols are supposed to lead to compact folded
state. Bolen and Baskakov demonstrated that the addition
of certain osmolytes results in the compaction of RNase
A[ 60]. Polyols have been shown to stabilize the acid-
unfolded molten globule state of cytochrome c by enhancing
hydrophobic interactions that overcome electrostatic repul-
sion at low pH between charged residues [61].
Glycerol has long been known as a protein stabilizer, and
its stabilization mechanism has been shown by Timasheﬀ
[62]. Glycerol leads to the enhancement of hydrophobic
interactions as a consequence of an increase in the solvent
orderingaroundproteins.Comparingwiththeotherpolyols,
glycerol is a mild stabilizer of protein conformation. Unlike
other polyols, Glycerol has unusual properties that decreases
the surface tension of water but increases its viscosity [63,
64]. Increasing glycerol concentrations are known to in-
crease the stability of proteins at all concentrations [62, 65]
although it decreases refolding at high concentrations due
to its ability to considerably slow down the kinetics of
refolding, which could result in oﬀ-pathway aggregation.
An optimum glycerol concentration seems to be critical for
striking a balance between its stabilizing eﬀect governed by
thermodynamic principles and its eﬀect on the kinetics of
folding glycerol successfully used in refolding of lysozyme
[66].
Sorbitol is another polyol that has been shown to reduce
aggregation of nucleocapsid protein of rhabdovirus after its
expression in Escherichia coli [67]. Sorbitol is likely to exert
its eﬀect on folding by altering the structure and properties
of water around the folding protein molecule.
Erythritol is also a protein structure stabilizer and
studies showed that it stabilizes proteins to lesser extents
compared with sorbitol [64]. The study on citrate synthase
aggregation kinetics during refolding in erythritol and other
polyols showed the ability of the polyols to stabilize proteins
depending on the number of hydroxyl groups in them [68].
9. Stimuli-ResponsivePolymers
Recently it has been shown that smart polymers can act as
a pseudochaperonins and precipitation of the protein from
its denatured solution by such polymers can yield refolded
active protein [69, 70]. Such polymers exist in soluble state
in aqueous buﬀers and can be made insoluble by application
of a stimulus. The latter can be a pH change, temperature
change, or a change in the concentration of chemical
species. This process is reversible. Table 2 represents the
smart polymers which are used in refolding of recombinant
proteins.
10. Conclusion
Obtaining a good amount of active protein at low cost
is the main objective in in vitro refolding of recombinant
protein from bacterial inclusion bodies but there is no
single refolding technique or method that satisﬁes all protein
refolding processes. With providing a good condition for in
vitro refolding of inclusion body, bacterial system could be
an excellent alternative to the mammalian expression system4 Biochemistry Research International
or other expression systems that can directly generate active
proteinswithacomplexdisulﬁdebondstructure.Inthispro-
cess, the solubilized target protein is subjected to refolding
using diﬀerent methods. Increasing protein concentrations
during the refolding process improves protein refolding and
the ﬁnal refolding yield. Refolding aiding chemicals are
helpful agents for increasing protein concentration especially
in dilution method. Therefore, application and optimization
of additives concentration is a main step in protein refolding
and should be done for each protein individually.
References
[1] E. D. B. Clark, “Refolding of recombinant proteins,” Current
Opinion in Biotechnology, vol. 9, no. 2, pp. 157–163, 1998.
[2] E. D. B. Clark, “Protein refolding for industrial processes,”
Current Opinion in Biotechnology, vol. 12, no. 2, pp. 202–207,
2001.
[3] A. P. J. Middelberg, “Preparative protein refolding,” Trends in
Biotechnology, vol. 20, no. 10, pp. 437–443, 2002.
[4] K. Tsumoto, D. Ejima, I. Kumagai, and T. Arakawa, “Practical
considerations in refolding proteins from inclusion bodies,”
Protein Expression and Puriﬁcation, vol. 28, no. 1, pp. 1–8,
2003.
[5] M. Alibolandi, H. Mirzahoseini, F. M. Nehi, G. Tabatabaian,
H. Amini, and S. Sardari, “Improving recombinant protein
solubility in Escherichia coli: identiﬁcation of best chaperone
combination which assists folding of human basic ﬁbroblast
growth factor,” African Journal of Biotechnology, vol. 9, no. 47,
pp. 8100–8109, 2010.
[6] H. Mirzahoseini, D. Shahbazzadeh, S. Enayati, M. Razzaghi
Abyaneh, and F. Mahboudi, “Medium eﬀect on heterologous
protein leaky expression in Escherichia coli,” in Modern
MutidisciplinaryAppliedMicrobiology,ExploitingMicrobesand
their Intractions, A. Mendez-Vilas, Ed., pp. 645–648, WILEY-
VCH, Weinheim, Germany, 2006.
[7] M. Alibolandi, H. Mirzahoseini, M. A. K. Abad, and M. A.
Movahed, “High level expression of human basic ﬁbroblast
growth factor in Escherichia coli: evaluating the eﬀe c to ft h e
GC content and rare codons within the ﬁrst 13 codons,”
African Journal of Biotechnology, vol. 9, no. 16, pp. 2456–2462,
2010.
[8] H. Mirzahoseini and M. Alibolandi, “Stability of recombinant
proteins in Escherichia coli: the eﬀect of co-expression of ﬁve
diﬀerentchaperonesets,”JournalofSciencesofIslamicRepublic
of Iran, vol. 20, no. 4, pp. 305–310, 2009.
[9] H. Mirzahoseini, A. Omumi, and E. Omidinia, “Investigation
of reasons that imply the diminished Inclusion Bodies in E.
coli,” Journal of Sciences of Islamic Republic of Iran, vol. 14, no.
2, pp. 113–119, 2003.
[10] Z. Huang and S. S. J. Leong, “Molecular-assisted refolding:
study of two diﬀerent ionic forms of recombinant human ﬁ-
broblast growth factors,” Journal of Biotechnology, vol. 142, no.
2, pp. 157–163, 2009.
[11] K. Mondal, H. B. Bohidar, R. P. Roy, and M. N. Gupta,
“Alginate-chaperoned facile refolding of Chromobacterium
viscosum lipase,” Biochimica et Biophysica Acta, vol. 1764, no.
5, pp. 877–886, 2006.
[12] K. Mondal, S. Raghava, B. Barua, R. Varadarajan, and M. N.
Gupta, “Role of stimuli-sensitive polymers in protein refold-
ing: α-Amylase and CcdB (controller of cell division or death
B) as model proteins,” Langmuir, vol. 23, no. 1, pp. 70–75,
2007.
[13] R. Kuboi, S. Morita, H. Ota, and H. Umakoshi, “Protein
refolding using stimuli-responsive polymer-modiﬁed aqueous
two-phasesystems,”JournalofChromatographyB,vol.743,no.
1-2, pp. 215–223, 2000.
[14] N. Yoshimoto, T. Hashimoto, M. Menayame Felix, H.
Umakoshi,andR.Kuboi,“Artiﬁcialchaperone-assistedrefold-
ing of bovine carbonic anhydrase using molecular assemblies
ofstimuli-responsivepolymers,”Biomacromolecules,vol.4,no.
6, pp. 1530–1538, 2003.
[15] Y. J. Chen, L. W. Huang, H. C. Chiu, and S. C. Lin,
“Temperature-responsive polymer-assisted protein refolding,”
Enzyme and Microbial Technology, vol. 32, no. 1, pp. 120–130,
2003.
[16] Z. Cui, Y. Guan, and S. Yao, “Temperature-sensitive hydrogel
refolding system: preparation of poly (N-isopropyl acry-
lamide) and its application in lysozyme refolding,” Chinese
Journal of Chemical Engineering, vol. 12, no. 4, pp. 556–560,
2004.
[ 1 7 ]X .T .W a n ga n dP .C .E n g e l ,“ A no p t i m i s e ds y s t e mf o r
refolding of human glucose 6-phosphate dehydrogenase,”
BMC Biotechnology, vol. 9, article number 19, 2009.
[18] J. Buchner and R. Rudolph, “Renaturation, puriﬁcation and
characterization of recombinant Fab-fragments produced in
Escherichia coli,” Nature Biotechnology, vol. 9, no. 2, pp. 157–
162, 1991.
[19] R. Rudolph and S. Fischer, “Process for obtaining renatured
proteins,” US Patent No. 4, pp: 434, 1990.
[20] W. J. Lin and J. A. Traugh, “Renaturation of casein kinase
II from recombinant subunits produced in Escherichia coli:
puriﬁcation and characterization of the reconstituted holoen-
zyme,” Protein Expression and Puriﬁcation,v o l .4 ,n o .3 ,p p .
256–264, 1993.
[21] J. Buchner, U. Brinkmann, and I. Pastan, “Renaturation of
a single-chain immunotoxin facilitated by chaperones and
protein disulﬁde isomerase,” Biotechnology,v o l .1 0 ,n o .6 ,p p .
682–685, 1992.
[22] M. H. Hsih, J. C. Kuo, and H. J. Tsai, “Optimization of
the solubilization and renaturation of ﬁsh growth hormone
produced by Escherichia coli,” Applied Microbiology and
Biotechnology, vol. 48, no. 1, pp. 66–72, 1997.
[23] D. Arora and N. Khanna, “Method for increasing the yield of
properly folded recombinant human gamma interferon from
inclusion bodies,” Journal of Biotechnology,v o l .5 2 ,n o .2 ,p p .
127–133, 1996.
[24] A. Rattenholl, H. Lilie, A. Grossmann, A. Stern, E. Schwarz,
and R. Rudolph, “The pro-sequence facilitates folding of
human nerve growth factor from Escherichia coli inclusion
bodies,” European Journal of Biochemistry, vol. 268, no. 11, pp.
3296–3303, 2001.
[25] S. Bell, S. Hansen, and J. Buchner, “Refolding and structural
characterization of the human p53 tumor suppressor protein,”
Biophysical Chemistry, vol. 96, no. 2-3, pp. 243–257, 2002.
[26] R. Asano, T. Kudo, K. Makabe, K. Tsumoto, and I. Kumagai,
“Antitumor activity of interleukin-21 prepared by novel
refolding procedure from inclusion bodies expressed in
Escherichia coli,” FEBS Letters, vol. 528, no. 1-3, pp. 70–76,
2002.
[27] H. Oneda and K. Inouye, “Refolding and recovery of recom-
binant human matrix metalloproteinase 7 (matrilysin) from
inclusion bodies expressed by Escherichia coli,” Journal of
Biochemistry, vol. 126, no. 5, pp. 905–911, 1999.
[28] D. L. Hevehan and E. D. B. Clark, “Oxidative renaturation of
lysozyme at high concentrations,” Biotechnology and Bioengi-
neering, vol. 54, no. 3, pp. 221–230, 1997.Biochemistry Research International 5
[29] K.Tsumoto,K.Shinoki,H.Kondo,M.Uchikawa,T.Juji,andI.
Kumagai, “Highly eﬃcient recovery of functional single-chain
Fv fragments from inclusion bodies overexpressed in Escher-
ichia coli by controlled introduction of oxidizing reagent-
application to a human single-chain Fv fragment,” Journal of
Immunological Methods, vol. 219, no. 1-2, pp. 119–129, 1998.
[30] U. Brinkmann, J. Buchner, and I. Pastan, “Independent do-
main folding of Pseudomonas exotoxin and single-chain im-
munotoxins: inﬂuence of interdomain connections,” Proceed-
ings of the National Academy of Sciences of the United States of
America, vol. 89, no. 7, pp. 3075–3079, 1992.
[ 3 1 ]P .H .Y a n c e y ,M .E .C l a r k ,S .C .H a n d ,R .D .B o w l u s ,a n dG .
N. Somero, “Living with water stress: evolution of osmolyte
systems,” Science, vol. 217, no. 4566, pp. 1214–1222, 1982.
[ 3 2 ]Y .X i a ,Y .D .P a r k ,H .M u ,H .M .Z h o u ,X .Y .W a n g ,a n dF .G .
Meng, “The protective eﬀects of osmolytes on arginine kinase
unfolding and aggregation,” International Journal of Biological
Macromolecules, vol. 40, no. 5, pp. 437–443, 2007.
[33] E. Bajorunaite, A. Cirkovas, K. Radzevicius, K. L. Larsen,
J. Sereikaite, and V. A. Bumelis, “Anti-aggregatory eﬀect of
cyclodextrins in the refolding process of recombinant growth
hormones from Escherichiacoli inclusion bodies,” Internation-
al Journal of Biological Macromolecules, vol. 44, no. 5, pp. 428–
434, 2009.
[34] L. Sharma and A. Sharma, “Inﬂuence of cyclodextrin ring
substituentsonfolding-relatedaggregationofbovinecarbonic
anhydrase,” European Journal of Biochemistry, vol. 268, no. 8,
pp. 2456–2463, 2001.
[35] R. Yazdanparast, M. A. Esmaeili, and F. Khodagholi, “Control
of aggregation in protein refolding: cooperative eﬀects of arti-
ﬁcial chaperone and cold temperature,” International Journal
of Biological Macromolecules, vol. 40, no. 2, pp. 126–133, 2007.
[36] R. Yazdanparast, F. Khodagholi, and R. Khodarahmi, “Artiﬁ-
cial chaperone-assisted refolding of chemically denatured α-
amylase,” International Journal of Biological Macromolecules,
vol. 35, no. 5, pp. 257–263, 2005.
[37] L. L. Y. Lee and J. C. Lee, “Thermal stability of proteins in the
presence of poly(ethylene glycols),” Biochemistry, vol. 26, no.
24, pp. 7813–7819, 1987.
[ 3 8 ]S .S a t o ,C .L .W a r d ,M .E .K r o u s e ,J .J .W i n e ,a n dR .R .
Kopito, “Glycerol reverses the misfolding phenotype of the
most common cystic ﬁbrosis mutation,” Journal of Biological
Chemistry, vol. 271, no. 2, pp. 635–638, 1996.
[ 3 9 ]H .S a w a n o ,Y .K o u m o t o ,K .O h t a ,Y .S a s a k i ,S .I .S e g a w a ,a n d
H. Tachibana, “Eﬃcient in vitro folding of the three-disulﬁde
derivatives of hen lysozyme in the presence of glycerol,” FEBS
Letters, vol. 303, no. 1, pp. 11–14, 1992.
[40] J. L. Cleland and D. I. C. Wang, “Cosolvent assisted protein
refolding,”NatureBiotechnology,vol.8,no.12,pp.1274–1278,
1990.
[41] A. Kozlowski and J. Milton Harris, “Improvements in protein
PEGylation: pegylated interferons for treatment of hepatitis
C,” Journal of Controlled Release, vol. 72, no. 1-3, pp. 217–224,
2001.
[42] M. J. Roberts, M. D. Bentley, and J. M. Harris, “Chemistry for
peptide and protein PEGylation,” Advanced Drug Delivery Re-
views, vol. 54, no. 4, pp. 459–476, 2002.
[43] B. Holtz, Y. Wang, X. Y. Zhu, and A. Guo, “Denaturing and
refolding of protein molecules on surfaces,” Proteomics, vol. 7,
no. 11, pp. 1771–1774, 2007.
[44] J. L. Cleland, S. E. Builder, J. R. Swartz, M. Winkler, J. Y.
Chang, and D. I. C. Wang, “Polyethylene glycol enhanced
protein refolding,” Nature Biotechnology, vol. 10, no. 9, pp.
1013–1019, 1992.
[45] J. L. Cleland, C. Hedgepeth, and D. I. Wang, “Polyethylene
glycol enhanced refolding of bovine carbonic anhydrase B.
Reaction stoichiometry and refolding model,” Journal of
Biological Chemistry, vol. 267, no. 19, pp. 13327–13334, 1992.
[46] W. Zielenkiewicz, R. Swierzewski, F. Attanasio, and G. Rialdi,
“Thermochemical, volumetric and spectroscopic properties
of lysozyme-poly(ethylene) glycol system,” Journal of Thermal
Analysis and Calorimetry, vol. 83, no. 3, pp. 587–595, 2006.
[47] F. Wang, Y. Liu, J. Li, G. Ma, and Z. Su, “On-column refolding
of consensus interferon at high concentration with guanidine-
hydrochloride and polyethylene glycol gradients,” Journal of
Chromatography A, vol. 1115, no. 1-2, pp. 72–80, 2006.
[48] F. Rahimpour, G. Mamo, F. Feyzi, S. Maghsoudi, and R.
Hatti-Kaul, “Optimizing refolding and recovery of active
recombinant Bacillus halodurans xylanase in polymer-salt
aqueous two-phase system using surface response analysis,”
JournalofChromatographyA,vol.1141,no.1,pp.32–40,2007.
[ 4 9 ]R .A .H a r t ,P .M .L e s t e r ,D .H .R e i f s n y d e r ,J .R .O g e z ,a n dS .
E. Builder, “Large scale, in situ isolation of periplasmic IGF-I
from E. coli,” Nature Biotechnology, vol. 12, no. 11, pp.
1113–1117, 1994.
[50] D. Samuel, T. K. S. Kumar, G. Ganesh et al., “Proline inhibits
aggregation during protein refolding,” Protein Science, vol. 9,
no. 2, pp. 344–352, 2000.
[51] S. H. Kim, Y. B. Yan, and H. M. Zhou, “Role of osmolytes as
chemical chaperones during the refolding of aminoacylase,”
Biochemistry and Cell Biology, vol. 84, no. 1, pp. 30–38, 2006.
[52] F. G. Meng, Y. D. Park, and H. M. Zhou, “Role of proline,
glycerol, and heparin as protein folding aids during refolding
of rabbit muscle creatine kinase,” International Journal of
BiochemistryandCellBiology,vol.33,no.7,pp.701–709,2001.
[53] A. S. Rudolph and J. H. Crowe, “Membrane stabilization dur-
ing freezing: the role of two natural cryoprotectants, trehalose
and proline,” Cryobiology, vol. 22, no. 4, pp. 367–377, 1985.
[54] B. Schobert and H. Tschesche, “Unusual solution properties
of proline and its interaction with proteins,” Biochimica et
Biophysica Acta, vol. 541, no. 2, pp. 270–277, 1978.
[55] C. Tanford, Physical Chemistry of Macromolecules,J o h nW i l e y
& Sons, New York, NY, USA, 1961.
[56] T. Arakawa and S. N. Timasheﬀ, “Mechanism of protein
salting in and salting out by divalent cation salts: balance
between hydration and salt binding,” Biochemistry, vol. 23,
no. 25, pp. 5912–5923, 1984.
[57] N. L. Jarvis and M. A. Scheiman, “Surface potentials of
aqueous electrolyte solutions,” Journal of Physical Chemistry,
vol. 72, no. 1, pp. 74–78, 1968.
[58] A.Hirano,H.Hamada,T.Okubo,T.Noguchi,H.Higashibata,
and K. Shiraki, “Correlation between thermal aggregation
and stability of lysozyme with salts described by molar surface
tension increment: an exceptional propensity of ammonium
salts as aggregation suppressor,” Protein Journal, vol. 26, no. 6,
pp. 423–433, 2007.
[59] W. Richter, T. Hermsdorf, T. Kronbach, and D. Dettmer,
“Refolding and puriﬁcation of recombinant human PDE7A
expressed in Escherichia coli as inclusion bodies,” Protein
Expression and Puriﬁcation, vol. 25, no. 1, pp. 138–148, 2002.
[60] D. W. Bolen and I. V. Baskakov, “The osmophobic eﬀect:
naturalselectionofathermodynamicforceinproteinfolding,”
JournalofMolecularBiology,vol.310,no.5,pp.955–963,2001.
[61] T. Kamiyama, Y. Sadahide, Y. Nogusa, and K. Gekko, “Polyol-
induced molten globule of cytochrome C: an evidence for
stabilization by hydrophobic interaction,” Biochimica et
Biophysica Acta, vol. 14, pp. 44–57, 1999.6 Biochemistry Research International
[62] S. N. Timasheﬀ, “Protein hydration, thermodynamic binding,
and preferential hydration,” Biochemistry, vol. 41, no. 46, pp.
13473–13482, 2002.
[63] K. Gekko and T. Morikawa, “Thermodynamics of polyol-
induced thermal stabilization of chymotrypsinogen,” Journal
of Biochemistry, vol. 90, no. 1, pp. 51–60, 1981.
[64] K. Gekko and S. N. Timasheﬀ, “Mechanism of protein sta-
bilization by glycerol: preferential hydration in glycerol-water
mixtures,” Biochemistry, vol. 20, no. 16, pp. 4667–4676, 1981.
[65] S. Jain and J. C. Ahluwalia, “Synergetic eﬀect of polyols with
tetrabutylammonium bromide and urea on the thermal
stability of lysozyme,” Thermochimica Acta, vol. 302, no. 1-2,
pp. 17–24, 1997.
[66] A. Cao, G. Wang, Y. Tang, and L. Lai, “Linear correlation
between thermal stability and folding kinetics of lysozyme,”
Biochemical and Biophysical Research Communications, vol.
291, no. 4, pp. 795–797, 2002.
[67] A. Majumder, S. Basak, T. Raha, S. P. Chowdhury, D.
Chattopadhyay, and S. Roy, “Eﬀe c to fo s m o l y t e sa n d
chaperone-like action of P-protein on folding of nucleocapsid
protein of chandipura virus,” Journal of Biological Chemistry,
vol. 276, no. 33, pp. 30948–30955, 2001.
[68] R. Mishra, R. Seckler, and R. Bhat, “Eﬃcient refolding of
aggregation-prone citrate synthase by polyol osmolytes: how
well are protein folding and stability aspects coupled?” Journal
of Biological Chemistry, vol. 280, no. 16, pp. 15553–15560,
2005.
[69] I. Roy and M. N. Gupta, “pH-responsive polymer-assisted
refolding of urea- and organic solvent-denatured α-chymot-
rypsin,” Protein Engineering, vol. 16, no. 12, pp. 1153–1157,
2003.
[70] I. Roy, K. Mondal, A. Sharma, and M. N. Gupta, “Simul-
taneous refolding/puriﬁcation of xylanase with a microwave
treated smart polymer,” Biochimica et Biophysica Acta, vol.
1747, no. 2, pp. 179–187, 2005.